181 related articles for article (PubMed ID: 7029297)
1. The Intergroup Rhabdomyosarcoma Study: update, november 1978.
Maurer HM
Natl Cancer Inst Monogr; 1981 Apr; (56):61-8. PubMed ID: 7029297
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in children with rhabdomyosarcoma.
Gehan EA; Glover FN; Maurer HM; Sutow WW; Hays DM; Lawrence W; Newton WA; Soule EH
Natl Cancer Inst Monogr; 1981 Apr; (56):83-92. PubMed ID: 7029299
[TBL] [Abstract][Full Text] [Related]
3. Multidisciplinary treatment of embryonal rhabdomyosarcoma in children: a progress report.
Ghavimi F; Exelby PR; Lieberman PH; Scott BF; Kosloff C
Natl Cancer Inst Monogr; 1981 Apr; (56):111-20. PubMed ID: 7029286
[TBL] [Abstract][Full Text] [Related]
4. Pathology of rhabdomyosarcoma: experience of the Intergroup Rhabdomyosarcoma Study, 1972-78.
Gaiger AM; Soule EH; Newton WA
Natl Cancer Inst Monogr; 1981 Apr; (56):19-27. PubMed ID: 7029289
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of intensified chemotherapy in children with advanced rhabdomyosarcoma (clinical groups III and IV). The Intergroup Rhabdomyosarcoma Study (IRS) Committee of the Cancer and Leukemia Group B Children's Cancer Study Group, Southwest Oncology Group.
Raney RB; Gehan EA; Maurer HM; Newton WA; Ragab AH; Ruymann FB; Sutow WW; Tefft M
Cancer Clin Trials; 1979; 2(1):19-28. PubMed ID: 391431
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in head and neck rhabdomyosarcoma.
Simon JH; Paulino AC; Smith RB; Buatti JM
Head Neck; 2002 May; 24(5):468-73. PubMed ID: 12001077
[TBL] [Abstract][Full Text] [Related]
7. Multidisciplinary treatment of advanced stages of embryonal rhabdomyosarcoma in children.
Ghavimi F; Exelby PR; Jereb B; Lieberman PH; Scott BF; Kosloff C
Natl Cancer Inst Monogr; 1981 Apr; (56):103-9. PubMed ID: 7029285
[TBL] [Abstract][Full Text] [Related]
8. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
Meza JL; Anderson J; Pappo AS; Meyer WH;
J Clin Oncol; 2006 Aug; 24(24):3844-51. PubMed ID: 16921036
[TBL] [Abstract][Full Text] [Related]
9. [Pediatric rhabdomyosarcoma of the infratemporal fossa].
Rozan O; Janot F; Oberlin O; Schwaab G; Quintana E; Tran Ba Huy P; Georges B; Luboinski B
Ann Otolaryngol Chir Cervicofac; 2002 Sep; 119(4):195-201. PubMed ID: 12410115
[TBL] [Abstract][Full Text] [Related]
10. Treatment of childhood rhabdomyosarcoma at St. Jude Children's Research Hospital, 1962--78.
Pratt CB; Hustu HO; Kumar AP; Johnson WW; Ransom JL; Howarth CB; George SL
Natl Cancer Inst Monogr; 1981 Apr; (56):93-101. PubMed ID: 7029301
[TBL] [Abstract][Full Text] [Related]
11. What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract?
Arndt CA; Donaldson SS; Anderson JR; Andrassy RJ; Laurie F; Link MP; Raney RB; Maurer HM; Crist WM
Cancer; 2001 Jun; 91(12):2454-68. PubMed ID: 11413538
[TBL] [Abstract][Full Text] [Related]
12. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors.
Carli M; Colombatti R; Oberlin O; Bisogno G; Treuner J; Koscielniak E; Tridello G; Garaventa A; Pinkerton R; Stevens M
J Clin Oncol; 2004 Dec; 22(23):4787-94. PubMed ID: 15570080
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of topotecan and cyclophosphamide given in a phase II window trial in children with newly diagnosed metastatic rhabdomyosarcoma: a Children's Oncology Group study.
Walterhouse DO; Lyden ER; Breitfeld PP; Qualman SJ; Wharam MD; Meyer WH
J Clin Oncol; 2004 Apr; 22(8):1398-403. PubMed ID: 15007087
[TBL] [Abstract][Full Text] [Related]
14. [The multidisciplinary treatment of rhabdomyosarcoma in childhood. A 10-year multicenter experience (1978-1988) in Liguria].
Vitali ML; Ricci G; Acquaviva A; Neri E; Cominetti M; Tomassini E; Boni L; Rasore-Quartino A; Bistolfi F; De Bernardi B
Pediatr Med Chir; 1993; 15(3):279-85. PubMed ID: 7692428
[TBL] [Abstract][Full Text] [Related]
15. Rhabdomyosarcoma in children--a ten year review.
Bradford WB; Jose BO; Butler D; Lindberg RD; Paris K; Spanos WJ; Patel CC; Bertolone SJ
J Ky Med Assoc; 1998 Oct; 96(10):399-402. PubMed ID: 9803061
[TBL] [Abstract][Full Text] [Related]
16. Special considerations related to primary site in rhabdomyosarcoma: experience of the Intergroup Rhabdomyosarcoma Study, 1972--76.
Raney RB; Donaldson MH; Sutow WW; Lindberg RD; Maurer HM; Tefft M
Natl Cancer Inst Monogr; 1981 Apr; (56):69-74. PubMed ID: 7300896
[TBL] [Abstract][Full Text] [Related]
17. Rhabdomyosarcomas: chemotherapy and limited supplementary treatment program to avoid mutilation.
Voûte PA; Vos A; de Kraker J; Behrendt H
Natl Cancer Inst Monogr; 1981 Apr; (56):121-5. PubMed ID: 7300888
[TBL] [Abstract][Full Text] [Related]
18. Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group.
Koscielniak E; Klingebiel TH; Peters C; Hermann J; Burdach ST; Bender-Götze C; Müller-Weihrich ST; Treuner J
Bone Marrow Transplant; 1997 Feb; 19(3):227-31. PubMed ID: 9028550
[TBL] [Abstract][Full Text] [Related]
19. Sarcoma of the prostate: a single institutional review.
Janet NL; May AW; Akins RS
Am J Clin Oncol; 2009 Feb; 32(1):27-9. PubMed ID: 19194120
[TBL] [Abstract][Full Text] [Related]
20. Rhabdomyosarcoma: an overview.
Dagher R; Helman L
Oncologist; 1999; 4(1):34-44. PubMed ID: 10337369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
